Newsroom

Christian Scherf, Josef Penninger, Berit Lange, Christos Pantazis

News

On March 14, 2024, representatives of the Helmholtz Centre for Infection Research (HZI) and the Helmholtz Association met with around 30 members of the Bundestag in Berlin. Prof. Josef Penninger, Scientific Director of the HZI, and Dr. Berit Lange, Acting Head of the HZI Department of Epidemiology, presented the current state of research on pandemic resilience at a parliamentary breakfast entitled "Mastering pandemics: Focus on resilience, innovation and cutting-edge international research". The patron of the event was Dr. Christos Pantazis, Member of the German Bundestag.

15.03.2024

HZI Campus

Electron micrograph of Pseudomonas aeruginosa

News

Pseudomonas aeruginosa is an important opportunistic pathogen responsible for life-threatening infections that are associated with high rates of morbidity and mortality. Researchers from TWINCORE, the Centre for Experimental and Clinical Infection Research in Hannover, and the Helmholtz Centre for Infection Research (HZI) in Braunschweig have now been able to show that an enzyme controls virulence through modification of tRNAs.

14.03.2024

HZI Campus

TWINCORE

News

On March 10, 2024, Prof. Tobias Welte, Director of the Clinic for Pneumology and Infectiology at Hannover Medical School (MHH), passed away unexpectedly at the age of 64. Welte was a long-standing close cooperation partner in joint research projects between the Helmholtz Centre for Infection Research (HZI) and the MHH, which resulted in numerous publications in renowned research journals.

12.03.2024

HZI Campus

TWINCORE

CiiM

[Translate to English:] Portrait Thekla Cordes

News

Despite modern immunotherapies and existing drugs, lung cancer patients often develop resistance to treatment. To close this gap, an international team including Thekla Cordes, professor for cell metabolism at Technische Universität Braunschweig at the Braunschweig Centre for Systems Biology (BRICS) and head of the research group “Cellular Metabolism in Infection” at the Helmholtz Centre for Infection Research (HZI), as well as researchers from the Salk Institute for Biological Studies (USA) and Yale University School (USA), investigated potential targets for cancer therapies. Their results have been published in the journal Cancer Discovery.

08.03.2024

BRICS

Prof Anna Hirsch and Dr Walid Elgaher sit in front of a laptop

News

New active substances for the treatment of resistant bacteria are needed more urgently than ever – yet only few candidates make the leap from research to clinical application. To facilitate precisely this transition, the US organization CARB-X provides targeted funding for advanced projects in antibiotics research. Saarbrücken researcher Anna Hirsch has now successfully acquired CARB-X funding for one of her innovative projects for the second time. The aim of the project, which is funded with up to 1.25 million US dollars, is to develop resistance-breaking antibiotics for the treatment of bacterial pneumonia.

04.03.2024

HIPS

News

The human cytomegalovirus, HCMV for short, lies dormant unnoticed in the body of most people for their entire lives. In immunocompromised individuals, however, the virus can cause life-threatening infections. It infects dendritic cells, a specific type of cell in the immune system. Although the majority of them are infected, only a few of them immediately execute the virus's genetic programme. Researchers at TWINCORE, Centre for Experimental and Clinical Infection Research, have now been able to show which signalling pathways of the innate immune system the virus is targeting in order to have itself produced by the host cells. They have published their findings in the journal Nature Communications. The TWINCORE is a joint institution of Hannover Medical School (MHH) and the Helmholtz Centre for Infection Research (HZI) in Braunschweig.

29.02.2024

HZI Campus

TWINCORE

HIRI

CiiM

Back to the first page
...
31
32
33
34
...
154

HZI in the media

... von verschiedenen Hörnchen, wie jüngste Erkenntnisse des Helmholtz Instituts für One Health in Greifswald kürzlich ...

26.03.2026

Tagesschau

zur Bekämpfung der Tuberkulose und des Helmholtz-Zentrums für Infektionsforschung erstellt. Zahlreiche weitere Fachgesellschaften und

24.03.2026

Deutsches Ärzteblatt

... fünf Teams durch, darunter PROTON vom Helmholtz-Zentrum für Infektionsforschung. Dieses entwickelt einen neuartigen Wirkstoff gegen ...

22.03.2026

Ad Hoc News

Vor allem durch die Coronapandemie sind Forschende des Helmholtz-Zentrums für Infektionsforschung in den vergangenen Jahren bundesweit bekannt geworden. Auf welche Themen die Einrichtung für die Zukunft setzt.

20.03.2026

Deutsches Ärzteblatt

... beschäftigt sich daneben unter dem Dach des Helmholtz Institutes für Pharmazeutische Forschung Saarland (HIPS) ...

18.03.2026

Biermann Medizin

... Ausbau von Produktions- und Vermarktungskapazitäten.

Das Helmholtz-Zentrum für Infektionsforschung HZI begrüßt den Erhalt der GMP- ...

18.03.2026

Bionity.COM

... der Universität zu Lübeck, des Helmholtz-Zentrums für Infektionsforschung (HZI) in Braunschweig, der Medizinischen Hochschule Hannover ...

17.03.2026

Biermann Medizin

Vorsorge Das Coronavirus hält die Welt nicht mehr in Atem. Doch was, wenn ein anderer gefährlicher Erreger auftaucht? So wappnet sich unser Gesundheitssystem

16.03.2026

Apotheken Umschau

... stumpfen ab“, erklärt Marc Brönstrup vom Helmholtz-Zentrum für Infektionsforschung in Braunschweig. Neue Antibiotika sind dringend ...

14.03.2026

ARD Mediathek

... der Medizinischen Hochschule Hannover und dem Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig neue Wirkstoffe ...

13.03.2026

MTA Dialog

... späten 1990ern hob sie der am Saarbrücker Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS) tätige ...

08.03.2026

Saarbrücker Zeitung

European institutions, including Germany’s Helmholtz Institute for RNA-based Infection Research, Helmholtz Center for Infection Research,

06.03.2026

Clinical Lab Products

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.